ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
63 hedge funds and large institutions have $11.9M invested in Endocyte, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 28 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
80% less call options, than puts
Call options by funds: $108K | Put options by funds: $542K
Holders
63
Holding in Top 10
–
Calls
$108K
Puts
$542K
Top Buyers
| 1 | +$274K | |
| 2 | +$246K | |
| 3 | +$136K | |
| 4 |
Renaissance Technologies
New York
|
+$122K |
| 5 |
Two Sigma Investments
New York
|
+$97K |
Top Sellers
| 1 | -$1.55M | |
| 2 | -$1.05M | |
| 3 | -$596K | |
| 4 |
Morgan Stanley
New York
|
-$522K |
| 5 |
Millennium Management
New York
|
-$337K |